ID: ALA3951061

Max Phase: Preclinical

Molecular Formula: C17H16N2O3

Molecular Weight: 296.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(Cc1ccccc1)C(=O)/C=C/c1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C17H16N2O3/c1-18(13-15-5-3-2-4-6-15)17(20)12-9-14-7-10-16(11-8-14)19(21)22/h2-12H,13H2,1H3/b12-9+

Standard InChI Key:  VDESPOCMEYSKBK-FMIVXFBMSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 296.33Molecular Weight (Monoisotopic): 296.1161AlogP: 3.27#Rotatable Bonds: 5
Polar Surface Area: 63.45Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.44CX LogD: 3.44
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.48Np Likeness Score: -1.20

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):